Bharat Biotech has announced the Phase 3 clinical trial results for its Coronavirus vaccine candidate Covaxin. The company said that Covaxin demonstrated an efficacy of 81 per cent in the trials.

Bharat Biotech announces successful Phase-3 trial results of Covaxin

covaxin-trial-results

Covaxin Trial Results, News on Covaxin Trial Results, stories on Covaxin Trial Results, articles on Covaxin Trial Results, Covaxin Trial Results stories at Wion, Covaxin Trial Results news, Covaxin Trial Results latest news

covaxin trial-results

Bharat Biotech announces successful Phase-3 trial results of Covaxin